Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0002007730-26-000002

SVP, Chief Accounting Officer sold 49,524 shares at $1.39 ($68,838)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Malabre Richard C · SVP, Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-02 Sale : show line 1 in the form 10b5-1 −36,142 $1.39 $50,237 312,772 D
2026-02-02 Sale : show line 2 in the form 10b5-1 −13,382 $1.39 $18,601 299,390 D
Open-market sales · 49,524 sh · avg $1.39 · $68,838
Loading xslF345X05/primarydocument.xml…